These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 37793738)

  • 1. Are There Any "Tips" for Better Joint Risk Factor Control in Patients With Diabetes?
    Sawami K; Tanaka A; Node K
    JACC Heart Fail; 2023 Oct; 11(10):1470. PubMed ID: 37793738
    [No Abstract]   [Full Text] [Related]  

  • 2. Reply: Are There Any "Tips" for Better Joint Risk Factor Control in Patients With Diabetes?
    Qi L
    JACC Heart Fail; 2023 Oct; 11(10):1471. PubMed ID: 37793739
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of transjugular intrahepatic portosystemic shunt (TIPS) on glycemic control in cirrhotic patients with diabetes mellitus.
    Deschênes M; Somberg KA
    Am J Gastroenterol; 1998 Mar; 93(3):483. PubMed ID: 9517672
    [No Abstract]   [Full Text] [Related]  

  • 4. Symptomatic Heart Failure After Transjugular Intrahepatic Portosystemic Shunt Placement: Incidence, Outcomes, and Predictors.
    Modha K; Kapoor B; Lopez R; Sands MJ; Carey W
    Cardiovasc Intervent Radiol; 2018 Apr; 41(4):564-571. PubMed ID: 29181605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonalcoholic Fatty Liver Disease and Diabetes Mellitus Are Associated With Post-Transjugular Intrahepatic Portosystemic Shunt Renal Dysfunction: An Advancing Liver Therapeutic Approaches Group Study.
    Ge J; Lai JC; Boike JR; German M; Jest N; Morelli G; Spengler E; Said A; Lee A; Hristov A; Desai AP; Junna S; Pokhrel B; Couri T; Paul S; Frenette C; Christian-Miller N; Laurito M; Verna EC; Rahim U; Goel A; Das A; Pine S; Gregory D; VanWagner LB; Kolli KP;
    Liver Transpl; 2021 Feb; 27(3):329-340. PubMed ID: 33217178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Observational cohort study of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt (TIPS).
    Routhu M; Safka V; Routhu SK; Fejfar T; Jirkovsky V; Krajina A; Cermakova E; Hosak L; Hulek P
    Ann Hepatol; 2017; 16(1):140-148. PubMed ID: 28051803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Percutaneous transhepatic balloon-assisted transjugular intrahepatic portosystemic shunt for chronic, totally occluded, portal vein thrombosis with symptomatic portal hypertension: procedure technique, safety, and clinical applications.
    Chen Y; Ye P; Li Y; Ma S; Zhao J; Zeng Q
    Eur Radiol; 2015 Dec; 25(12):3431-7. PubMed ID: 25903717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Factors for Acute Transjugular Intrahepatic Portosystemic Shunt Occlusion Using Expanded Polytetrafluoroethylene-Covered Stent.
    Wang X; Luo X; Zhao M; Song J; Li X; Yang L
    Dig Dis Sci; 2020 Oct; 65(10):3032-3039. PubMed ID: 31853780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Prospective Study Identifying Predictive Factors of Cardiac Decompensation After Transjugular Intrahepatic Portosystemic Shunt: The Toulouse Algorithm.
    Billey C; Billet S; Robic MA; Cognet T; Guillaume M; Vinel JP; Péron JM; Lairez O; Bureau C
    Hepatology; 2019 Dec; 70(6):1928-1941. PubMed ID: 31512743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Refractory Hepatic Encephalopathy After Elective Transjugular Intrahepatic Portosystemic Shunt: Risk Factors and Outcomes with Revision.
    Rowley MW; Choi M; Chen S; Hirsch K; Seetharam AB
    Cardiovasc Intervent Radiol; 2018 Nov; 41(11):1765-1772. PubMed ID: 29872892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of transjugular intrahepatic portosystemic shunt on glycometabolism in cirrhosis patients.
    Su AP; Cao SS; Le Tian B; Da Zhang Z; Hu WM; Zhang Y; Wang ZL; Babu SR; Hu T
    Clin Res Hepatol Gastroenterol; 2012 Feb; 36(1):53-9. PubMed ID: 22099870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complications of transjugular intrahepatic portosystemic shunt (TIPS) in the era of the stent graft - What the interventionists need to know?
    Patel RK; Chandel K; Tripathy TP; Mukund A
    Eur J Radiol; 2021 Nov; 144():109986. PubMed ID: 34619618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension.
    Colombato L
    J Clin Gastroenterol; 2007; 41 Suppl 3():S344-51. PubMed ID: 17975487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Segmental intrahepatic cholestasis as a technical complication of the transjugular intrahepatic porto-systemic shunt.
    Bucher JN; Hollenbach M; Strocka S; Gaebelein G; Moche M; Kaiser T; Bartels M; Hoffmeister A
    World J Gastroenterol; 2019 Nov; 25(43):6430-6439. PubMed ID: 31798279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and Efficacy of Microwave Ablation for Hepatocellular Carcinoma in the Setting of Transjugular Intrahepatic Portosystemic Shunt.
    Yan J; Ying X; Malhotra A; Talenfeld A; Charalel R; Lee KS; Trost D; Kesselman A
    Cardiovasc Intervent Radiol; 2022 May; 45(5):578-581. PubMed ID: 34859308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Shunting branch of portal vein and stent position predict survival after transjugular intrahepatic portosystemic shunt.
    Bai M; He CY; Qi XS; Yin ZX; Wang JH; Guo WG; Niu J; Xia JL; Zhang ZL; Larson AC; Wu KC; Fan DM; Han GH
    World J Gastroenterol; 2014 Jan; 20(3):774-85. PubMed ID: 24574750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complications During Transjugular Intrahepatic Portosystemic Shunt Creation.
    Shah RP; Sze DY
    Tech Vasc Interv Radiol; 2016 Mar; 19(1):61-73. PubMed ID: 26997090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lower-Extremity Edema Is Common after Transjugular Intrahepatic Portosystemic Shunt Creation and Is Associated with Lower Survival: A Two-Institution Study.
    Rostambeigi N; Farsad K; Young S; Shrestha P; Jahangiri Y; Liang KW; Cretcher M; Golzarian J
    Radiology; 2021 Jan; 298(1):221-227. PubMed ID: 33201792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of Improvement of Sarcopenia after Transjugular Intrahepatic Portosystemic Shunt Creation in Cirrhotic Patients.
    Huang S; Liu J; Cai J; Zhou C; Wang Y; Yang C; Li T; Chen Y; Ju S; Wang C; Yao W; Bai Y; Xiong B
    J Vasc Interv Radiol; 2023 Apr; 34(4):639-644. PubMed ID: 36586464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Refining prediction of survival after TIPS with the novel Freiburg index of post-TIPS survival.
    Bettinger D; Sturm L; Pfaff L; Hahn F; Kloeckner R; Volkwein L; Praktiknjo M; Lv Y; Han G; Huber JP; Boettler T; Reincke M; Klinger C; Caca K; Heinzow H; Seifert LL; Weiss KH; Rupp C; Piecha F; Kluwe J; Zipprich A; Luxenburger H; Neumann-Haefelin C; Schmidt A; Jansen C; Meyer C; Uschner FE; Brol MJ; Trebicka J; Rössle M; Thimme R; Schultheiss M
    J Hepatol; 2021 Jun; 74(6):1362-1372. PubMed ID: 33508376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.